212 related articles for article (PubMed ID: 37312098)
1. Effect of aerobic exercise training on the fat fraction of the liver in persons with chronic hepatitis B and hepatic steatosis: Trial protocol for a randomized controlled intervention trial- The FitLiver study.
Jespersen S; Plomgaard P; Madsbad S; Hansen AE; Bandholm T; Pedersen BK; Ritz C; Weis N; Krogh-Madsen R
Trials; 2023 Jun; 24(1):398. PubMed ID: 37312098
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis reveals exercise training induced remodelling of hepatokine secretion and uncovers syndecan-4 as a regulator of hepatic lipid metabolism.
De Nardo W; Miotto PM; Bayliss J; Nie S; Keenan SN; Montgomery MK; Watt MJ
Mol Metab; 2022 Jun; 60():101491. PubMed ID: 35381388
[TBL] [Abstract][Full Text] [Related]
4. Moderate-Intensity Aerobic vs Resistance Exercise and Dietary Modification in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial.
Charatcharoenwitthaya P; Kuljiratitikal K; Aksornchanya O; Chaiyasoot K; Bandidniyamanon W; Charatcharoenwitthaya N
Clin Transl Gastroenterol; 2021 Mar; 12(3):e00316. PubMed ID: 33939383
[TBL] [Abstract][Full Text] [Related]
5. Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C--a randomized trial.
Rusu E; Jinga M; Enache G; Rusu F; Dragomir AD; Ancuta I; Draguţ R; Parpala C; Nan R; Sima I; Ateia S; Stoica V; Cheţa DM; Radulian G
Nutr J; 2013 Aug; 12():119. PubMed ID: 23941362
[TBL] [Abstract][Full Text] [Related]
6. Effects of an exercise program on hepatic metabolism, hepatic fat, and cardiovascular health in overweight/obese adolescents from Bogotá, Colombia (the HEPAFIT study): study protocol for a randomized controlled trial.
González-Ruíz K; Correa-Bautista JE; Izquierdo M; García-Hermoso A; Dominguez-Sanchez MA; Bustos-Cruz RH; García-Prieto JC; Martínez-Vizcaíno V; Lobelo F; González-Jiménez E; Prieto-Benavides DH; Tordecilla-Sanders A; Schmidt-RioValle J; Perez G; Ramírez-Vélez R
Trials; 2018 Jun; 19(1):330. PubMed ID: 29941024
[TBL] [Abstract][Full Text] [Related]
7. Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B.
Mak LY; Hui RW; Fung J; Liu F; Wong DK; Cheung KS; Yuen MF; Seto WK
J Hepatol; 2020 Oct; 73(4):800-806. PubMed ID: 32504663
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of high-intensity, low-volume interval training compared to continuous aerobic training on insulin resistance, skeletal muscle structure and function in adults with metabolic syndrome: study protocol for a randomized controlled clinical trial (Intraining-MET).
Gallo-Villegas J; Aristizabal JC; Estrada M; Valbuena LH; Narvaez-Sanchez R; Osorio J; Aguirre-Acevedo DC; Calderón JC
Trials; 2018 Feb; 19(1):144. PubMed ID: 29482601
[TBL] [Abstract][Full Text] [Related]
9. Evidence of hepatic glucagon resistance associated with hepatic steatosis: reversal effect of training.
Charbonneau A; Couturier K; Gauthier MS; Lavoie JM
Int J Sports Med; 2005; 26(6):432-41. PubMed ID: 16037884
[TBL] [Abstract][Full Text] [Related]
10. Relations of hepatic steatosis with liver functions, inflammations, glucolipid metabolism in chronic hepatitis B patients.
Chen XL; Han YD; Wang H
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5640-5646. PubMed ID: 30229840
[TBL] [Abstract][Full Text] [Related]
11. Predictors of hepatic steatosis in HBeAg-negative chronic hepatitis B patients and their diagnostic values in hepatic fibrosis.
Zheng RD; Xu CR; Jiang L; Dou AX; Zhou K; Lu LG
Int J Med Sci; 2010 Aug; 7(5):272-7. PubMed ID: 20714438
[TBL] [Abstract][Full Text] [Related]
12. Time-restricted eating and supervised exercise for improving hepatic steatosis and cardiometabolic health in adults with obesity: protocol for the TEMPUS randomised controlled trial.
Camacho-Cardenosa A; Clavero-Jimeno A; Martin-Olmedo JJ; Amaro-Gahete F; Cupeiro R; Cejudo MTG; García Pérez PV; Hernández-Martínez C; Sevilla-Lorente R; De-la-O A; López-Vázquez A; Molina-Fernandez M; Carneiro-Barrera A; Garcia F; Rodríguez-Nogales A; Gálvez Peralta JJ; Cabeza R; Martín-Rodríguez JL; Muñoz-Garach A; Muñoz-Torres M; Labayen I; Ruiz JR
BMJ Open; 2024 Jan; 14(1):e078472. PubMed ID: 38267239
[TBL] [Abstract][Full Text] [Related]
13. Influence of upper-body continuous, resistance or high-intensity interval training (CRIT) on postprandial responses in persons with spinal cord injury: study protocol for a randomised controlled trial.
McMillan DW; Maher JL; Jacobs KA; Mendez AJ; Nash MS; Bilzon JLJ
Trials; 2019 Aug; 20(1):497. PubMed ID: 31409383
[TBL] [Abstract][Full Text] [Related]
14. Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial).
Bacchi E; Negri C; Targher G; Faccioli N; Lanza M; Zoppini G; Zanolin E; Schena F; Bonora E; Moghetti P
Hepatology; 2013 Oct; 58(4):1287-95. PubMed ID: 23504926
[TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis B associated with hepatic steatosis, insulin resistance, necroinflammation and fibrosis.
Yilmaz B; Koklu S; Buyukbayram H; Yalçin K; Korkmaz U; Posul E; Can G; Kurt M
Afr Health Sci; 2015 Sep; 15(3):714-8. PubMed ID: 26957957
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle hypertrophy and attenuation of cardio-metabolic risk factors (SHARC) using functional electrical stimulation-lower extremity cycling in persons with spinal cord injury: study protocol for a randomized clinical trial.
Gorgey AS; Khalil RE; Davis JC; Carter W; Gill R; Rivers J; Khan R; Goetz LL; Castillo T; Lavis T; Sima AP; Lesnefsky EJ; Cardozo CC; Adler RA
Trials; 2019 Aug; 20(1):526. PubMed ID: 31443727
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of clinical and pathological features of chronic hepatitis B with hepatic steatosis].
Mi YQ; Liu YG; Xu L; Fan JG; Zhang H; Ping L; Shi RF
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):817-20. PubMed ID: 19958639
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of Jian-Pi Huo-Xue granule for non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled trial.
Sun Y; Chen G; Chen S; Wang Y; Hu Y; Zhao Y
Trials; 2022 Jun; 23(1):455. PubMed ID: 35655225
[TBL] [Abstract][Full Text] [Related]
19. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
20. The effects of aerobic exercise on body composition in overweight and obese patients with gout: a randomized, open-labeled, controlled trial.
Jia E; Zhu H; Geng H; Liu R; Wo X; Zeng Y; Ma W; Yao X; Zhan Z; Zhang J
Trials; 2022 Sep; 23(1):745. PubMed ID: 36064594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
